NEWTOWN, Pa., March 09, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for ...

PARIS — High-frequency repetitive transcranial magnetic stimulation (rTMS) is safe and effective in managing ataxia in patients with relapsing-remitting multiple sclerosis (RRMS), new research ...

Cancer is a multifactorial disease that manifests in several different ways depending on its point of origin. Often, the symptoms offer strong clues as to which organ is diseased. In some cases, ...

The first patient was a 13-year-old boy born at term to healthy, consanguineous parents with no family history of neurodevelopmental disorder. Pregnancy and labor were unremarkable, and his ...

NEW YORK (Reuters Health) - Older patients with mild cognitive impairment often exhibit gait dysfunction, or difficulty walking, according to findings published in the Journal of the American ...

Ataxia-telangiectasia (A-T) is an autosomal recessive chromosome breakage disorder caused by mutations in the ATM gene. Typically, it presents in early childhood with progressive cerebellar ...

SURREY, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) -- The Surrey Neuroplasticity Clinic is pleased to announce that it will recommence the use of the Portable Neuromodulation Stimulator (PoNS™) ...

At least one in 100 horses at some point in its life will lose the ability to control its gait as a result of developing the neurological disorder ataxia. Once found to be ataxic, the horse is often ...